483 Aurobindo Pharma May 2018

483 Aurobindo Pharma May 2018

Marie Buen-Bigornia FDA, Niketa Patel FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma - Mahabubnagar District, India facility and issued inspectional observations (via FDA 483) on 04 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 04 May 2018
  • Location: Mahabubnagar District, India
  • FEI: 3011905047
Add To Cart